Home/Filings/4/0001702824-25-000010
4//SEC Filing

Bell Michael Brian 4

Accession 0001702824-25-000010

CIK 0001576280other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 7:17 PM ET

Size

12.3 KB

Accession

0001702824-25-000010

Insider Transaction Report

Form 4
Period: 2025-12-15
Bell Michael Brian
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-15+1,23329,285 total
  • Exercise/Conversion

    Common Stock

    2025-12-15+2,03931,324 total
  • Tax Payment

    Common Stock

    2025-12-15$102.67/sh1,659$170,33029,665 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-151,2331,233 total
    Exercise: $0.00Common Stock (1,233 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-152,0394,078 total
    Exercise: $0.00Common Stock (2,039 underlying)
Footnotes (4)
  • [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  • [F2]This represents a restricted stock unit award granted on May 9, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
  • [F3]Not applicable for Restricted Stock Units.
  • [F4]This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Issuer

Guardant Health, Inc.

CIK 0001576280

Entity typeother

Related Parties

1
  • filerCIK 0001702824

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:17 PM ET
Size
12.3 KB